Marco Menabrito

Head Of Customer Success at Univfy

Marco Menabrito has over 18 years of experience in the medical field. Marco began their career in 2002 as an Assistant at Escandon Hospital. In 2003, they began working as an M.D. at ABC Medical Center and as a Pre-graduation Intern and Assistant in the Provision of Medical Services. In 2004, they worked as a Medical Responsible at Sandoz and a Pharmacovigilance Internship at Pfizer Pharmaceuticals. In 2006, they became a Medical Manager at Merck Serono. In 2012, they were appointed as Global Therapeutic Area Lead at Medtronic Spine & Biologics. In 2014, they became the European Medical Director Fertility & Obstetrics at Ferring Pharmaceuticals. In 2017, they were appointed as Global Marketing Director at Gedeon Richter - PregLem S.A. and, most recently, in 2022, they became the Head of Customer Success, Provider Solutions at Univfy.

Marco Menabrito has an extensive education history. Marco obtained their Doctor of Medicine (M.D.) from Universidad Anáhuac in 2004. In 2005 and 2006, they obtained their MBA from Universidad de Alcalá and their Master of Business Administration - MBA from Talento-EPHOS, respectively. In 2017, they attended London Business School for a Market Driving Strategies program. In 2021, they obtained a Diploma of Education from IESE Business School and in 2022 they will attend Stanford University School of Medicine for an AI in Healthcare program. In addition to their formal education, Marco has obtained several certifications, such as Introduction to Healthcare from Stanford Online in 2022, Executive Leadership from LinkedIn Learning in 2021, Fundamental Neuroscience for Neuroimaginv from The Johns Hopkins University in 2021, Leadership Group Coaching from The Black Swan Group in 2020, Inbound Certified and Inbound Sales Certified from HubSpot in 2020, and Inbound Marketing Certification from HubSpot in 2020.

Links

Previous companies

Medtronic logo
Sandoz logo
Pfizer logo
Ferring Pharmaceuticals logo

Timeline

  • Head Of Customer Success

    February, 2022 - present